文献速递瓣膜病与结构性心脏病心律失常

二尖瓣环钙化合并重度主动脉瓣狭窄:经导管主动脉瓣置换术前后的患病率、特征与结局

Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement.
PubMed 文献 · Eur Heart J · 2017-01-01

在761例接受TAVR的重度AS患者中,49.3%存在二尖瓣环钙化(MAC),其中重度MAC占9.5%;30天死亡率和主要并发症在有/无MAC患者间相似;重度MAC是TAVR术后全因死亡、心血管死亡及新发永久起搏器植入的独立预测因素。

要点

  • 重度AS拟行TAVR患者中约半数合并MAC,重度MAC占9.5%。
  • 有/无MAC患者30天死亡率和主要并发症相似。
  • 重度MAC独立预测TAVR术后全因死亡(HR 1.95)和心血管死亡(HR 2.35)。

核心结论

  • 约半数拟行TAVR的重度AS患者存在MAC,重度MAC与TAVR术后全因死亡、心血管死亡及传导异常相关,应纳入未来TAVR风险分层模型。

研究设计与样本

  • 连续接受TAVR的患者按术前CT是否存在MAC及其严重程度分组比较。
  • 全队列共761例患者。

主要发现

  • 49.3%存在MAC,50.7%无MAC;轻度MAC 231例(30.4%),中度MAC 72例(9.5%),重度MAC 72例(9.5%)。
  • 有MAC与无MAC患者30天死亡率和主要并发症相似。
  • 多变量生存分析显示,重度MAC是TAVR术后全因死亡的独立强预测因素(HR 1.95,95%CI 1.24-3.07,P=0.004)。
  • 重度MAC是TAVR术后心血管死亡的独立强预测因素(HR 2.35,95%CI 1.19-4.66,P=0.01)。
  • 重度MAC是TAVR术后新发永久起搏器植入的独立强预测因素(OR 2.83,95%CI 1.08-7.47,P=0.03)。

临床怎么用

  • 作者认为重度MAC应纳入未来TAVR风险分层模型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Calcified aortic stenosis (AS) and mitral annular calcification (MAC) have certain similar etiology and pathophysiological mechanisms. MAC is frequently encountered in pre-procedural computed tomography (CT) imaging of patients that undergo transcatheter aortic valve replacement (TAVR), but its prognostic implications for these patients have not been thoroughly investigated. This study sought to evaluate the prevalence of MAC among patients with severe AS and to assess the clinical implications of MAC on these patients during and following TAVR. METHODS AND RESULTS: Consecutive patients that underwent TAVR were compared according to the existence of MAC and its severity in pre-TAVR CT scans. From the entire cohort of 761 patients, 49.3% had MAC, and 50.7% did not have MAC. Mild MAC was present in 231 patients (30.4%), moderate MAC in 72 patients (9.5%), and severe MAC in 72 patients (9.5%). Thirty-day mortality and major complications were similar between patients with and without MAC. In a multivariable survival analysis, severe MAC was found to be an independent strong predictor of overall mortality following TAVR (all-cause mortality: hazards ratio [HR] 1.95, 95% confidence interval [CI] 1.24-3.07, P = 0.004; cardiovascular mortality: HR 2.35, 95% CI 1.19-4.66; P = 0.01). Severe MAC was also found to be an independent strong predictor of new permanent pacemaker implantation (PPI) after TAVR (OR 2.83, 95% CI 1.08-7.47; P = 0.03). CONCLUSION: Half of the patients with severe AS evaluated for TAVR were found to have MAC. Severe MAC is associated with increased all-cause and cardiovascular mortality and with conduction abnormalities following TAVR and should be included in future risk stratification models for TAVR.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Abramowitz Y, Kazuno Y, Chakravarty T, et al. Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement. Eur Heart J. 2017. PMID: 28039339. doi:10.1093/eurheartj/ehw594

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。